Frederikssund, Denmark

Jan Martin Overgard

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jan Martin Overgard: Innovator in Pharmaceutical Compositions

Introduction

Jan Martin Overgard is a notable inventor based in Frederikssund, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that are resistant to abuse while providing controlled release. His work is crucial in addressing the challenges associated with pain management and medication misuse.

Latest Patents

Jan Martin Overgard holds 2 patents related to abuse-deterrent pharmaceutical compositions. His latest patents focus on formulations that are not only abuse-resistant but also facilitate controlled release. These compositions are designed to be effective in the treatment of pain, ensuring that patients receive the necessary relief while minimizing the risk of misuse.

Career Highlights

Overgard's career is marked by his dedication to innovation in the pharmaceutical industry. He has been instrumental in advancing the development of safer medication options. His expertise in creating compositions that deter abuse showcases his commitment to improving patient care and safety.

Collaborations

Throughout his career, Jan Martin Overgard has collaborated with esteemed colleagues, including Peter Holm Tygesen and Karsten Lindhardt. These partnerships have contributed to the successful development of his innovative pharmaceutical compositions.

Conclusion

Jan Martin Overgard's work in the field of pharmaceuticals highlights the importance of innovation in creating safer medication options. His contributions are vital in addressing the dual challenges of pain management and the prevention of drug abuse.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…